Blood Grouping Reagents Market Research Report - Global Forecast till 2027

Blood Grouping Reagents Market Research Report: Information by Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027

ID: MRFR/HC/9241-CR | November 2021 | Region: Global | 142 pages

Blood Grouping Reagents Market Overview:


Global Blood Grouping Reagents Market size is projected to be worth USD 2,642.17 million by 2027, registering a CAGR of 7.74% during the forecast period (2021 - 2027), The market was valued at USD 1,578.78 million in 2020


Blood grouping reagents are solutions that can be used to identify ABO, Rhesus, Kell and MNS blood groups. These classifications of human blood are based on the presence or absence of antigens on the surface of red blood cells. The reagents can affect the agglutination (clumping) on the test red blood cells which transfer antigen. No clumping of the test red blood cells can specify the absence of a certain antigen.


The blood grouping reagents market has been segmented into products, technique, test type, end user, and region. The market is driven by factors such as growing prevalence of chronic disorders and increasing spending in medical research. However, concern pertaining to efficiency and proficiency of test kits hinder the growth of this market.


COVID-19 Analysis


The emergence of coronavirus negatively impacted various sectors across the globe. The healthcare sector was also negatively impacted owing to production restrictions, cessation of clinical trials, and R&D activities. However, the increasing number of COVID-19 patients require blood grouping reagent products on a large scale for diagnostic applications. The increasing number of assay techniques to confirm the presence or absence of coronavirus among patients is creating huge demand across the globe. The sudden surge in diagnostic tests created pressure among the market players to produce blood grouping reagent products. In addition, the rising number of molecular assay tests and RT-PCR tests for confirmation of disease is driving the demand for blood grouping reagent products.


Market Dynamics



  • Increasing prevalence of chronic disorders

    • The increasing prevalence of chronic disorders is propelling the demand for effective treatment. Chronic diseases such as anemia, hemophilia, lymphoma, diabetes, and leukemia, along with the ongoing COVID-19 pandemic, account for a substantial burden. The Center for Disease Control (CDC) in 2019 states that six in ten adults suffer from chronic disease while four in ten suffer from more than two chronic diseases. The data demonstrates the rising burden in terms of diseases and their effective management.

    • Moreover, according to the WHO, anemia affects more than 1.62 billion people across the globe, nearly 24.8% of the global population. Additionally, women of reproductive age are also affected with anemia due to iron deficiency. The women aging 15-49 are prevalent to anemia. The WHO reported that in 2019, 29.9% of the women aged 15-49 years agonized from anemia. Additionally, in 2019, 39.8% of children aged 6-59 months were affected by anemia.



  • Increasing spending in medical research


Market Restraints



  • Concern pertaining to the efficiency and accuracy of test kits

    • The blood grouping reagent test kits demand rose during the COVID-19 outbreak. The increasing usage of blood typing kits, RT-PCR kits, and serology test kits surge the sales of the market players. However, many complaints were registered about the inaccurate test results of the rapid test kits during the pandemic era. The immediate need for the test kits on a large scale might have compromised the quality of the product. In addition, the government authority ordered to perform serological tests on the defined hotspots with a population highly exposed to the coronavirus.




Market Opportunities



  • Emergence of automated blood grouping devices

    • The increasing number of blood grouping diagnostics and the rising population has created the demand for automated blood grouping devices. The fully automated systems can perform a large number of tests in a single input, further increasing productivity and efficiency within the stipulated timeline. These devices are programmed to carry out consistent test procedures with high accuracy while preventing contamination across the samples.

    • Moreover, the market players are offering fully automated blood typing devices with remote access features for enhanced monitoring and result validation. In addition, this equipment has specific features of tube size and diameter recognition, integrated quality control program, random position for samples, real-time information about the reagent and sample status, and high-definition color results, among others.




Value Chain Analysis


The global blood grouping reagents market is showing significant growth owing to the increasing hereditary disorders, high exposure to chemical toxins, and radioactive materials. The value chain analysis for the market comprises four major components, research & development and product designing, manufacturing, distribution & sales, and post-sales review.


Segment Overview


By Product



  • Consumables


Blood grouping reagents include several consumables, including Anti-A, Anti-B, Anti-AB, Anti-D, Anti-D (PK 1), Anti-D (PK 2), control reagents, and phenotyping reagents as Anti-C, Anti-E, Anti-c, Anti-e, Anti-K. Companies such as Merck KGaA, Bio-Rad Laboratories Inc, Novacyt SA, Beckman Coulter, Inc., Grifols SA, Immucor, Inc., among others, offer a wide range of consumables supporting the market demand.



  • Instruments


The blood grouping instrument is used to determine blood type by performing ABO grouping, Rh typing, antibody screening, and cross matching tests. These instruments are utilized to analyze the blood groups and offer several benefits over tests performed manually by technicians, such as a reduction in human errors. For instance, the IH-500 system by Bio-Rad Laboratories Inc. (US) incorporates a 6-axis robot transport arm and offers a high level of automation and minimizes user operations.


By Technique



  • PCR-based and Microarray Technique


The increasing pace of development in molecular biological techniques has directly affected mass testing and diagnostic applications, including blood screening. Polymerase chain reaction (PCR) and microarray techniques have been successfully applied to blood grouping. PCR-based assays can be used to predict the antigen type of donor RBCs for transfusion and antibody identification reagent panels.



  • Assay-Based Techniques


An assay-based technique is an analytic procedure used for blood grouping. Solid-phase assays such as ELISA and bead-based technology, including the Luminex method, are used for blood grouping. Solid-phase assays use reagent antigens or antibodies affixed to a surface (usually a microplate).  Several automated analyzers use solid-phase assays for blood grouping. For instance, Abcam Plc (UK), provides Human ABO ELISA Kit (Histo-Blood Group ABO System Transferase).



  • Massively Parallel Sequencing Techniques


Massively parallel sequencing techniques provide a comprehensive blood-group variant profile. However, this technique is dependent on labor-intensive data analysis by experts in blood-group genomics—a lack of trained workforce restraints the growth of this technique.



  • Serology


Serology is an analytic technique used for the diagnostic identification of antibodies in the serum that involves typing for antigens found on the surface of blood cells. However, this technique has certain limitations and cannot respond to the growing demand for blood products type for a large number of antigens. The serology segment is further be sub-segmented into gel technique, erythrocytes magnetized technology (EMT), solid-phase red-cell adherence (SPRCA), glass slide, glass tube, cassette/kits, and others.



  • Other Techniques


The other techniques are expected to register a CAGR of 7.39%.


By Test Type



  • Blood Group and Phenotype


The phenotype of RBCs refers to determining the type of antigens present on the RBC. The 'type and screen' determines both the ABO-Rh of the patient and screens for the presence of the most commonly found unexpected antibodies. It is performed on all patients requiring transfusions. However, an extended antigen phenotype may also be performed.



  • Antibody Screening


The antibody screening is done to check whether an antibody to a red cell antigen has been produced. Antibody screening is performed to detect antibodies in patients requiring blood transfusion, pregnant women, patients with suspected transfusion reactions, and blood and plasma donors.



  • Cross-matching Tests


Crossmatching tests are among the most important serological tests and are performed before a blood transfusion to ensure that the donor blood is compatible. It involves adding the recipient's plasma to the donor blood cells and observing for agglutination reactions.



  • Antibody Identification


Antibody identification involves analysis for the presence or absence of a particular antibody (qualitative) or the amount of antibody present (quantitative). The antibody identification testing is done for several applications, including documenting exposure to an infectious or foreign agent, evaluating immune status against a particular microorganism, diagnosing an autoimmune condition, diagnosing the reason for a transfusion reaction or a rejection of a transplanted organ, diagnosing an allergy, and monitoring the course of an infection or autoimmune process.



  • Coombs Tests


A Coombs test, also known as antiglobulin test, is either of two blood tests used in immunohematology. They are the direct and indirect Coombs tests. A direct Coombs test is performed to detect if antibodies are bound to red blood cells inside the person's body, which is abnormal and can occur in conditions like autoimmune hemolytic anemia, hemolytic disease of the newborn and transfusion reactions. The indirect Coombs test is used to screen for antibodies that could cause transfusion reactions and identify certain blood group antigens.



  • Antigen Typing


Antigen typing is performed if patients are found with clinically significant autoantibodies. The procedure is performed for the corresponding antigens to confirm if the antibodies are alloantibodies or autoantibodies. Also, if such a patient requires blood transfusion, all donor units to be crossmatched are antigen typed.


By End User



  • Hospitals


A person usually visits a clinic or hospital to find out their blood type. In clinics and hospitals, a doctor or nurse draws a blood sample and sends it to a lab for testing. Hospital-based laboratories are attached to the hospital, and the laboratory staff are employed by the hospital. These laboratories perform laboratory testing for inpatients and outpatients.



  • Blood Banks


Blood banking tasks primarily include collecting, processing, testing, storing, and distributing whole blood and blood products. According to the American National Red Cross, about 6.8 million people in the US donate blood each year. A certain set of standard tests are done in the lab once blood is donated, including ABO grouping and Rh typing.



  • Clinical Laboratories


Clinical laboratories are independent organizations or companies that test the product and material according to the requirements. The testing carried out by independent laboratories is known as "third-party" testing. These clinical laboratories offer advanced testing services and potentially provide a cost-saving alternative to hospitals and clinics lacking the infrastructure.


Regional Analysis


GLOBAL BLOOD GROUPING REAGENTS MARKET SHARE (%), BY Region, 2020
GLOBAL BLOOD GROUPING REAGENTS MARKET SHARE (%), BY REGION, 2020
Source: MRFR analysis


North America


North America dominated the global blood grouping market due to the presence of major manufacturers, increasing prevalence of chronic diseases leading to the high demand for blood transfusion and organ transplant


The key factors such as presence of major manufacturers, increasing prevalence of chronic diseases leading to the high demand for blood transfusion and organ transplant, technological advancements in the clinical segment, and increasing awareness among the population are expected to drive market growth. The key manufacturers are anticipated to launch new products, collaborate for optimization of the cash flow channel, and partially outsource the production process. Moreover, increasing investments in research and collaborative approach to improve the technology for blood grouping in the region is anticipated to increase the market size over the forecast period.


Asia-Pacific


Asia-Pacific presents lucrative opportunities for players operating in the blood grouping reagents market


The blood grouping reagents market in Asia-Pacific is expected to be the fastest-growing regional market. Key factors that influence the markets growth include the growing incidence of traumatic injuries from accidents and trauma in the region. Increasing demand for blood banking services, government initiatives and increasing public awareness about blood donation are driving the markets growth in this region. Globally, road accidents are the tenth leading cause of death. India accounted for about 500,000 road accidents in 2019, one of the highest in the world, in which about 150,000 people die and another 300,000 became crippled. In 2018, India had 467,044 reported road accidents, an increase of 0.5% from 464,910 in 2017, according to the road ministry's data. Moreover, in 2018, 63,194 traffic accident fatalities were recorded by China's National Bureau of Statistics. Many road accidents causing traumatic injuries are anticipated to increase the demand for blood grouping reagents in the region.


Competitive Landscape


The global blood grouping reagents market is expected to grow significantly in the coming years due to the increasing chronic diseases across the globe. The global blood grouping reagents market is characterized by the presence of several global, regional, and local vendors. The market is highly competitive, with all the players trying to gain maximum market share. Frequent changes in government policies, intense competition, and FDA regulations are the key factors that impact global market growth. The vendors compete based on cost, product quality, reliability, and aftermarket services. It is crucial for the players to offer cost-efficient and high-quality blood grouping reagents products to succeed in an intensely competitive market environment.


List of companies with HQ



  • Merck KGaA (Germany)

  • Bio-Rad Laboratories, Inc (US)

  • Novacyt Group (France)

  • Beckman Coulter, Inc (US)

  • Haemokinesis Pty Ltd (Australia)

  • MTC Med. Produkte GmbH (Germany)

  • DAY medical SA (Switzerland),

  • Rapid Labs Ltd (UK),

  • Ortho Clinical Diagnostics (US)

  • Diagast SAS (France)

  • Yuvraj Biobiz Incubator India Pvt (India)

  • Tulip Diagnostics (India)

  • Aikang (China)


Recent Developments



  • In July 2020, Merck KGaA invested 18 million euros in new life science laboratory in Switzerland. The laboratory facility is to be built in Buchs (Switzerland) to support the growth of the company in the reference materials.

  • In April 2018, Quotient Limited received FDA approval for U.S. commercialization of seven new blood bank reagents.

  • In December 2017, Beckman Coulter, Inc. expanded its development & manufacturing facility based in Lismeehan, County Clare (Ireland). At this facility, the company develops and manufactures reagents used in clinical chemistry, hematology, and immunochemistry product.


Report Overview


The study covers the existing short-term and long-term market effects. It helps decision-makers to draught short-term and long-term business plans by region. The report covers major regions in North North America, Europe, Asia-Pacific, and the Rest of the World. The report analyzes market drivers, restraints, opportunities, challenges, Porter's five forces, value chain, and impact of COVID-19 on the market.


Study Objectives



  • To provide a comprehensive analysis of the global blood grouping reagents market and its sub-segments, thereby providing a detailed structure of the industry

  • To provide detailed insights into factors driving and restraining the growth of the global blood grouping reagents market

  • To estimate the market size of the blood grouping reagents market where 2018 to 2019 would be the historical period, 2020 shall be the base year, and 2021 to 2027 will be forecast period for the study

  • To provide strategic profiling of key companies (manufacturers and distributors) present across the countries, and comprehensively analyze their competitiveness/competitive landscape in this market

  • To provide a value chain analysis for the blood grouping reagents market.


Market Segmentation:


Global Blood Grouping Reagents Market, By Product



  • Consumables

  • Instruments

    • Fully automated

    • Semi-automated




Global Blood Grouping Reagents Market, By Technique



  • PCR-based and Microarray Technique

  • Assay-Based Techniques

  • Massively Parallel Sequencing Techniques

  • Serology

    • Gel Technique

    • Erythrocytes Magnetised Technology (EMT)

    • Solid-Phase Red-Cell Adherence (SPRCA)

    • Glass Slide and Tubes

    • Cassette/Kit

    • Others



  • Other Techniques


Global Blood Grouping Reagents Market, By Test Type



  • Blood Group and Phenotype

  • Antibody Screening

  • Cross-matching Tests

  • Antibody Identification

  • Coombs Tests

  • Antigen Typing


Global Blood Grouping Reagents Market, By End User



  • Hospitals

  • Blood Banks

  • Clinical Laboratories


Global Blood Grouping Reagents Market, By Region



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America





Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 2,642.17 Million
  CAGR   7.74%
  Base Year   2020
  Forecast Period   2021-2027
  Historical Data   2018 & 2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Products, Technique, Test Type, End User, and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World
  Key Vendors   Merck KGaA (Germany), Bio-Rad Laboratories, Inc (US), Novacyt Group (France), Beckman Coulter, Inc (US), Haemokinesis Pty Ltd (Australia), MTC Med. Produkte GmbH (Germany), DAY medical SA (Switzerland), Rapid Labs Ltd (UK), Ortho Clinical Diagnostics (US), Diagast SAS (France), and others
  Key Market Opportunities   • Emergence of automated medical devices
  Key Market Drivers   • Increasing prevalence of chronic disorders • Increasing spending in medical research


Speak to Analyst Ask for Customization

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY

2.2 RESEARCH OBJECTIVE

2.3 MARKET STRUCTURE

2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

3.1 DATA MINING

3.2 SECONDARY RESEARCH

3.3 PRIMARY RESEARCH

3.4 BREAKDOWN OF PRIMARY RESPONDENTS

3.5 FORECASTING TECHNIQUES

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION

3.6.1 BOTTOM-UP APPROACH

3.6.2 TOP-DOWN APPROACH

3.7 DATA TRIANGULATION

3.8 VALIDATION

4 MARKET DYNAMICS

4.1 OVERVIEW

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF CHRONIC DISORDERS

4.2.2 INCREASING SPENDING IN MEDICAL RESEARCH

4.3 RESTRAINT

4.3.1 CONCERNS PERTAINING TO THE EFFICIENCY AND ACCURACY OF TEST KITS

4.4 OPPORTUNITY

4.4.1 EMERGENCE OF AUTOMATED BLOOD GROUPING DEVICES

4.5 TECHNOLOGICAL DISRUPTION

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D AND DESIGNING

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.1.4 POST-SALES REVIEW

5.2 PORTER'S FIVE FORCES MODEL

5.2.1 BARGAINING POWER OF BUYERS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF NEW ENTRANTS

5.2.4 THREAT OF SUBSTITUTES

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19

5.3.1 IMPACT ON DEMAND

5.3.2 IMPACT ON SUPPLY CHAIN

5.4 VOLUME OF TESTS FOR DONATED BLOOD, BY REGION, 2020

5.5 BLOOD TRANSFUSION VOLUME, BY REGION, 2020

6 GLOBAL BLOOD GROUPING REAGENTS, BY PRODUCT

6.1 OVERVIEW

6.2 CONSUMABLES

6.3 INSTRUMENTS

6.3.1 FULLY-AUTOMATED INSTRUMENTS

6.3.2 SEMI-AUTOMATED INSTRUMENTS

7 GLOBAL BLOOD GROUPING REAGENTS, BY TECHNIQUE

7.1 OVERVIEW

7.2 PCR-BASED AND MICROARRAY TECHNIQUE

7.3 ASSAY-BASED TECHNIQUES

7.4 MASSIVELY PARALLEL SEQUENCING TECHNIQUES

7.5 SEROLOGY

7.5.1 GEL TECHNIQUE

7.5.2 EMT

7.5.3 SPRCA

7.5.4 GLASS SLIDE AND TUBES

7.5.5 CASSETTE/KIT

7.5.6 OTHER SEROLOGY

7.6 OTHER TECHNIQUES

8 GLOBAL BLOOD GROUPING REAGENTS, BY TEST TYPE

8.1 OVERVIEW

8.2 BLOOD GROUP AND PHENOTYPES

8.3 ANTIBODY SCREENING

8.4 CROSSMATCHING TESTS

8.5 ANTIBODY IDENTIFICATION

8.6 COOMBS TEST

8.7 ANTIGEN TYPING

9 GLOBAL BLOOD GROUPING REAGENTS, BY END USER

9.1 OVERVIEW

9.2 HOSPITALS

9.3 BLOOD BANKS

9.4 CLINICAL LABORATORIES

10 GLOBAL BLOOD GROUPING REAGENTS MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 UK

10.3.3 FRANCE

10.3.4 SPAIN

10.3.5 ITALY

10.3.6 REST OF EUROPE

10.4 ASIA PACIFIC

10.4.1 CHINA

10.4.2 JAPAN

10.4.3 INDIA

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 MIDDLE EAST

10.5.2 AFRICA

10.5.3 LATIN AMERICA

11 COMPETITIVE LANDSCAPE

11.1 COMPETITIVE OVERVIEW

11.2 MAJOR PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET

11.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET

11.4 COMPETITIVE BENCHMARKING

11.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES

11.6.2 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

11.7 MAJOR PLAYERS FINANCIAL MATRIX

11.7.1 REVENUE OF MAJOR PLAYERS, 2020

11.7.2 R&D EXPENDITURE

12 COMPANY PROFILES

12.1 MERCK KGAA

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 KEY DEVELOPMENTS

12.1.5 SWOT ANALYSIS

12.1.6 KEY STRATEGIES

12.2 BIO-RAD LABORATORIES, INC.

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 KEY DEVELOPMENTS

12.2.5 SWOT ANALYSIS

12.2.6 KEY STRATEGIES

12.3 NOVACYT GROUP

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCTS/SERVICES OFFERED

12.3.4 KEY DEVELOPMENTS

12.3.5 KEY STRATEGIES

12.4 BECKMAN COULTER, INC.

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 KEY DEVELOPMENTS

12.4.5 KEY STRATEGIES

12.5 HAEMOKINESIS PTY LTD

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 KEY DEVELOPMENTS

12.5.5 KEY STRATEGIES

12.6 MTC MED. PRODUKTE GMBH

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS/SERVICES OFFERED

12.6.4 KEY DEVELOPMENTS

12.6.5 KEY STRATEGIES

12.7 DAY MEDICAL SA

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 KEY DEVELOPMENTS

12.7.5 KEY STRATEGIES

12.8 RAPID LABS LTD

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 KEY DEVELOPMENTS

12.8.5 KEY STRATEGIES

12.9 ORTHO CLINICAL DIAGNOSTICS

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 PRODUCTS OFFERED

12.9.4 KEY DEVELOPMENTS

12.9.5 SWOT ANALYSIS

12.9.6 KEY STRATEGIES

12.10 DIAGAST SAS

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 PRODUCTS/SERVICES OFFERED

12.10.4 KEY DEVELOPMENTS

12.10.5 KEY STRATEGIES

12.11 GRIFOLS SA

12.11.1 COMPANY OVERVIEW

12.11.2 FINANCIAL OVERVIEW

12.11.3 PRODUCTS/SERVICES OFFERED

12.11.4 KEY DEVELOPMENTS

12.11.5 SWOT ANALYSIS

12.11.6 KEY STRATEGIES

12.12 IMMUCOR, INC.

12.12.1 COMPANY OVERVIEW

12.12.2 FINANCIAL OVERVIEW

12.12.3 PRODUCTS/SERVICES OFFERED

12.12.4 KEY DEVELOPMENTS

12.12.5 SWOT ANALYSIS

12.12.6 KEY STRATEGIES

12.13 QUOTIENT LTD

12.13.1 COMPANY OVERVIEWS

12.13.2 FINANCIAL OVERVIEW

12.13.3 PRODUCTS/SERVICES OFFERED

12.13.4 KEY DEVELOPMENTS

12.13.5 SWOT ANALYSIS

12.13.6 KEY STRATEGIES

12.14 YUVRAJ BIOBIZ INCUBATOR INDIA PVT LTD

12.14.1 COMPANY OVERVIEW

12.14.2 FINANCIAL OVERVIEW

12.14.3 PRODUCTS/SERVICES OFFERED

12.14.4 KEY DEVELOPMENTS

12.14.5 KEY STRATEGIES

12.15 TULIP DIAGNOSTICS

12.15.1 COMPANY OVERVIEW

12.15.2 FINANCIAL OVERVIEW

12.15.3 PRODUCTS/SERVICES OFFERED

12.15.4 KEY DEVELOPMENTS

12.15.5 KEY STRATEGIES

12.16 AIKANG

12.16.1 COMPANY OVERVIEW

12.16.2 FINANCIAL OVERVIEW

12.16.3 PRODUCTS/SERVICES OFFERED

12.16.4 KEY DEVELOPMENTS

12.16.5 KEY STRATEGIES

12.17 INTEC

12.17.1 COMPANY OVERVIEW

12.17.2 FINANCIAL OVERVIEW

12.17.3 PRODUCTS OFFERED

12.17.4 KEY DEVELOPMENTS

12.17.5 KEY STRATEGIES

13 APPENDIX

13.1 REFERENCES

13.2 RELATED REPORTS


LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS

TABLE 3 PREVALENCE OF TRANSFUSION-TRANSMISSIBLE INFECTIONS IN BLOOD DONATIONS (MEDIAN, INTERQUARTILE RANGE (IQR)), BY INCOME GROUPS

TABLE 4 AVERAGE VOLUME OF TESTS, BY REGION (MILLION)

TABLE 5 AVERAGE BLOOD TRANSFUSION VOLUME, BY REGION (MILLION UNITS)

TABLE 6 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018–2027 (USD MILLION)

TABLE 7 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CONSUMABLES, BY REGION, 2018–2027 (USD MILLION)

TABLE 8 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR INSTRUMENTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 9 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR INSTRUMENTS, BY TYPE, 2018–2027 (USD MILLION)

TABLE 10 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR FULLY-AUTOMATED, BY REGION, 2018–2027 (USD MILLION)

TABLE 11 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SEMI-AUTOMATED, BY REGION, 2018–2027 (USD MILLION)

TABLE 12 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018–2027 (USD MILLION)

TABLE 13 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR PCR-BASED AND MICROARRAY TECHNIQUE, BY REGION, 2018–2027 (USD MILLION)

TABLE 14 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ASSAY-BASED TECHNIQUES, BY REGION, 2018–2027 (USD MILLION)

TABLE 15 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR MASSIVELY PARALLEL SEQUENCING TECHNIQUES, BY REGION, 2018–2027 (USD MILLION)

TABLE 16 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SEROLOGY, BY REGION, 2018–2027 (USD MILLION)

TABLE 17 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SEROLOGY, BY TYPE, 2018–2027 (USD MILLION)

TABLE 18 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR GEL TECHNIQUE, BY REGION, 2018–2027 (USD MILLION)

TABLE 19 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR EMT, BY REGION, 2018–2027 (USD MILLION)

TABLE 20 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR SPRCA, BY REGION, 2018–2027 (USD MILLION)

TABLE 21 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR GLASS SLIDE AND TUBES, BY REGION, 2018–2027 (USD MILLION)

TABLE 22 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CASSETTE/KIT, BY REGION, 2018–2027 (USD MILLION)

TABLE 23 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR OTHER SEROLOGY, BY REGION, 2018–2027 (USD MILLION)

TABLE 24 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR OTHER TECHNIQUES, BY REGION, 2018–2027 (USD MILLION)

TABLE 25 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018–2027 (USD MILLION)

TABLE 26 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR BLOOD GROUP AND PHENOTYPE, BY REGION, 2018–2027 (USD MILLION)

TABLE 27 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ANTIBODY SCREENING, BY REGION, 2018–2027 (USD MILLION)

TABLE 28 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CROSS-MATCHING TESTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 29 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ANTIBODY IDENTIFICATION, BY REGION, 2018–2027 (USD MILLION)

TABLE 30 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR COOMBS TESTS, BY REGION, 2018–2027 (USD MILLION)

TABLE 31 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR ANTIGEN TYPING, BY REGION, 2018–2027 (USD MILLION)

TABLE 32 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018–2027 (USD MILLION)

TABLE 33 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR HOSPITALS, BY REGION, 2018–2027 (USD MILLION)

TABLE 34 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR BLOOD BANKS, BY REGION, 2018–2027 (USD MILLION)

TABLE 35 GLOBAL: BLOOD GROUPING REAGENTS MARKET, FOR CLINICAL LABORATORIES, BY REGION, 2018–2027 (USD MILLION)

TABLE 36 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 37 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 38 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 39 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 40 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 41 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 42 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 43 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 44 US: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 45 US: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 46 US: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 47 US: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 48 US: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 49 US: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 50 CANADA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 51 CANADA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 52 CANADA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 53 CANADA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 54 CANADA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 55 CANADA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 56 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 57 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 58 EUROPE: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 59 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 60 EUROPE: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 61 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 62 EUROPE: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 63 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 64 GERMANY: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 65 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 66 GERMANY: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 67 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 68 GERMANY: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 69 UK: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 70 UK: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 71 UK: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 72 UK: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 73 UK: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 74 UK: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 75 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 76 FRANCE: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 77 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 78 FRANCE: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 79 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 80 FRANCE: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 81 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 82 SPAIN: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 83 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 84 SPAIN: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 85 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 86 SPAIN: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 87 ITALY: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 88 ITALY: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 89 ITALY: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 90 ITALY: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 91 ITALY: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 92 ITALY: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 93 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 94 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 95 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 96 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 97 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 98 REST OF EUROPE: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 99 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY COUNTRY, 2018–2027 (USD MILLION)

TABLE 100 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 101 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 102 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 103 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 104 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 105 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 106 CHINA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 107 CHINA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 108 CHINA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 109 CHINA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 110 CHINA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 111 CHINA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 112 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 113 JAPAN: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 114 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 115 JAPAN: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 116 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 117 JAPAN: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 118 INDIA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 119 INDIA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 120 INDIA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 121 INDIA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 122 INDIA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 123 INDIA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 124 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 125 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 126 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 127 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 128 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 129 SOUTH KOREA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 130 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 131 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 132 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 133 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 134 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 135 AUSTRALIA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 136 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 137 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 138 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 139 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 140 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 141 REST OF ASIA-PACIFIC: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 142 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY REGION, 2018–2027 (USD MILLION)

TABLE 143 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 144 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 145 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 146 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 147 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 148 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 149 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 150 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 151 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 152 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 153 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 154 MIDDLE EAST: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 155 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 156 AFRICA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 157 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 158 AFRICA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 159 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 160 AFRICA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 161 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 162 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET FOR INSTRUMENTS, BY PRODUCT, 2018-2027 (USD MILLION)

TABLE 163 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 164 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET FOR SEROLOGY, BY TECHNIQUE, 2018-2027 (USD MILLION)

TABLE 165 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2018-2027 (USD MILLION)

TABLE 166 LATIN AMERICA: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2018-2027 (USD MILLION)

TABLE 167 MAJOR PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET

TABLE 168 THE MOST ACTIVE PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET

TABLE 169 NEW PRODUCT DEVELOPMENTS/LAUNCHES

TABLE 170 COLLABORATIONS/EXPANSIONS/PARTNERSHIPS/INVESTMENTS

TABLE 171 MERCK KGAA: PRODUCTS OFFERED

TABLE 172 MERCK KGAA: KEY DEVELOPMENTS

TABLE 173 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED

TABLE 174 NOVACYT GROUP: PRODUCTS/SERVICES OFFERED

TABLE 175 BECKMAN COULTER, INC.: PRODUCTS OFFERED

TABLE 176 BECKMAN COULTER, INC.: KEY DEVELOPMENTS

TABLE 177 HAEMOKINESIS PTY LTD: PRODUCTS OFFERED

TABLE 178 MTC MED. PRODUKTE GMBH: PRODUCTS/TECHNOLOGIES OFFERED

TABLE 179 DAY MEDICAL SA: PRODUCTS/TECHNOLOGIES OFFERED

TABLE 180 RAPID LABS LTD: PRODUCTS OFFERED

TABLE 181 ORTHO CLINICAL DIAGNOSTICS: PRODUCTS OFFERED

TABLE 182 DIAGAST SAS: PRODUCTS/SERVICES OFFERED

TABLE 183 GRIFOLS SA: PRODUCTS/SERVICES OFFERED

TABLE 184 IMMUCOR, INC.: PRODUCTS/SERVICES OFFERED

TABLE 185 QUOTIENT LTD: PRODUCTS/SERVICES OFFERED

TABLE 186 QUOTIENT LTD: KEY DEVELOPMENTS

TABLE 187 YUVRAJ BIOBIZ INCUBATOR INDIA PVT LTD: PRODUCTS/SERVICES OFFERED

TABLE 188 TULIP DIAGNOSTICS: PRODUCTS/SERVICES OFFERED

TABLE 189 AIKANG: PRODUCTS/SERVICES OFFERED

TABLE 190 INTEC: PRODUCTS OFFERED


LIST OF FIGURES

FIGURE 1 MARKET SYNOPSIS

FIGURE 2 MARKET STRUCTURE: GLOBAL BLOOD GROUPING REAGENTS MARKET

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES

FIGURE 4 MARKET DYNAMICS: GLOBAL BLOOD GROUPING REAGENTS MARKET

FIGURE 5 DRIVERS: IMPACT ANALYSIS

FIGURE 6 RESTRAINT: IMPACT ANALYSIS

FIGURE 7 VALUE CHAIN: GLOBAL BLOOD GROUPING REAGENTS MARKET

FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL BLOOD GROUPING REAGENTS MARKET

FIGURE 9 GLOBAL BLOOD GROUPING REAGENTS MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION)

FIGURE 10 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TECHNIQUE, 2020 & 2027 (USD MILLION)

FIGURE 11 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY TEST TYPE, 2020 & 2027 (USD MILLION)

FIGURE 12 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY END USER, 2020 & 2027 (USD MILLION)

FIGURE 13 GLOBAL: BLOOD GROUPING REAGENTS MARKET, BY REGION 2020 & 2027 (USD MILLION)

FIGURE 14 NORTH AMERICA: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY 2020 (%)

FIGURE 15 EUROPE: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 16 ASIA PACIFIC: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY COUNTRY, 2020

FIGURE 17 REST OF THE WORLD: BLOOD GROUPING REAGENTS MARKET SHARE (%), BY REGION, 2020

FIGURE 18 THE MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL BLOOD GROUPING REAGENTS MARKET

FIGURE 19 BENCHMARKING OF MAJOR COMPETITORS

FIGURE 20 REVENUE OF MAJOR PLAYERS, 2020

FIGURE 21 MAJOR PLAYERS R&D EXPENDITURE 2020

FIGURE 22 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 23 MERCK KGAA: SWOT ANALYSIS

FIGURE 24 BIO-RAD LABORATORIES, INC.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 25 BIO-RAD LABORATORIES, INC.: SWOT ANALYSIS

FIGURE 26 NOVACYT GROUP: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 27 ORTHO CLINICAL DIAGNOSTICS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 ORTHO CLINICAL DIAGNOSTICS: SWOT ANALYSIS

FIGURE 29 GRIFOLS SA: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 GRIFOLS SA: SWOT ANALYSIS

FIGURE 31 IMMUCOR, INC.: SWOT ANALYSIS

FIGURE 32 QUOTIENT LTD: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 33 QUOTIENT LTD: SWOT ANALYSIS



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.